Results 331 to 338 of about 168,140 (338)
Some of the next articles are maybe not open access.
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer.
New England Journal of MedicineBACKGROUND
The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative chemoradiotherapy.J. Hoeppner, Thomas Brunner, C. Schmoor, P. Bronsert, B. Kulemann, R. Claus, Stefan Utzolino, J. R. Izbicki, Ines Gockel, Berthold Gerdes, M. Ghadimi, Benedikt Reichert, J. F. Lock, Christiane J. Bruns, Ernst Reitsamer, Maximillian Schmeding, F. Benedix, Tobias Keck, G. Folprecht, P. Thuss-Patience, U. P. Neumann, Andreas Pascher, Detlef Imhof, S. Daum, Tanja Strieder, Christian Krautz, Simone Zimmermann, Jens Werner, Rolf Mahlberg, G. Illerhaus, Peter P. Grimminger, F. Lordick +31 moresemanticscholar +1 more sourceChemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
Journal of Clinical Oncology, 1998 PURPOSE
The Southwest Oncology Group (SWOG) coordinated an Intergroup study with the participation of Radiation Therapy Oncology Group (RTOG), and Eastern Cooperative Oncology Group (ECOG).M. al-Sarraf, M. LeBlanc, P. Giri, K. Fu, J. Cooper, T. Vuong, A. Forastiere, G. Adams, W. Sakr, D. Schuller, J. Ensley +10 moresemanticscholar +1 more sourceAvelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
The Lancet Oncology, 2021 N. Lee, R. Ferris, A. Psyrri, R. Haddad, M. Tahara, J. Bourhis, K. Harrington, P. Chang, Jin-Ching Lin, M. Razaq, M. M. Teixeira, J. Lövey, J. Chamois, A. Rueda, Chaosu Hu, L. Dunn, M. Dvorkin, Steven De Beukelaer, D. Pavlov, H. Thurm, Ezra E. W. Cohen +20 moresemanticscholar +1 more sourceNeoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
The Lancet Oncology, 2015 J. Shapiro, J. V. van Lanschot, M. Hulshof, P. van Hagen, M. I. van Berge Henegouwen, B. Wijnhoven, H. V. van Laarhoven, G. Nieuwenhuijzen, G. Hospers, J. Bonenkamp, M. Cuesta, R. Blaisse, O. Busch, F. T. Ten Kate, G. Creemers, C. Punt, J. Plukker, H. Verheul, E. Bilgen, H. van Dekken, M. J. van der Sangen, T. Rozema, K. Biermann, J. Beukema, A. Piet, C. M. Van rij, J. Reinders, H. Tilanus, E. Steyerberg, A. van der Gaast +29 moresemanticscholar +1 more sourceA bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy
Nature Biomedical Engineering, 2019 H. Yi, Y. Jeong, Yona Kim, Yeong-Jin Choi, H. Moon, Sung Hye Park, K. S. Kang, Mihyeon Bae, Jinah Jang, Hyewon Youn, S. Paek, D. Cho +11 moresemanticscholar +1 more sourcePreoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1).
European Journal of Cancer, 2020 Chengqiang Li, Shengguang Zhao, Yuyan Zheng, Yichao Han, Xiaoyan Chen, Zenghui Cheng, Yuquan Wu, Xijia Feng, W. Qi, Kai Chen, J. Xiang, Jian Li, T. Lerut, Hecheng Li +13 moresemanticscholar +1 more sourceInduction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.
The Lancet Oncology, 2016 Ying Sun, Wen-Fei Li, N. Chen, Ning Zhang, G. Hu, F. Xie, Yan Sun, Xiaozhong Chen, Jin-Gao Li, Xiao-dong Zhu, Chaosu Hu, Xiangying Xu, Yuanyuan Chen, Wei‐han Hu, Ling Guo, H. Mo, Lei Chen, Y. Mao, R. Sun, P. Ai, S. Liang, Guo-Xian Long, B. Zheng, Xinglai Feng, X. Gong, Ling Li, Chunying Shen, Jian-yu Xu, Ying Guo, Yu-Ming Chen, Fan Zhang, Li Lin, L. Tang, Mengzhong Liu, Jun Ma +34 moresemanticscholar +1 more source
